Literature DB >> 29695647

A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels.

Hideyuki Okuma1, Koshi Hashimoto1,2, Takuya Ohashi1, Masatomo Mihara1, Isao Minami1, Hajime Izumiyama1,3, Shigekazu Sasaki4, Naoko Inoshita5, Hiroshi Nishioka6, Shozo Yamada6, Takanobu Yoshimoto1.   

Abstract

A 29-year-old man was referred to our department due to adrenal insufficiency with the inappropriate secretion of TSH (SITSH). Magnetic resonance imaging revealed a pituitary tumor. A weak TSH response in the TRH test, elevated sex hormone binding globulin (SHBG) levels, and the absence of a family medical history of SITSH or TRβ gene mutations supported the diagnosis of TSH-secreting pituitary adenoma (TSHoma). However, complete TSH suppression and a blunted cholesterol response in the T3 suppression test as well as normal glycoprotein α-subunit (α-GSU) levels were not compatible with TSHoma. Since TSH, FT3, and FT4 spontaneously returned to normal ranges after admission, he was discharged. One month after his discharge, thyrotoxicosis with elevated serum TSH levels relapsed. After admission, his serum TSH levels returned to within the normal range. After his discharge from the second admission, his serum TSH levels fluctuated in accordance with serum FT3 and FT4 levels and symptoms, such as palpitations. Ten months after his discharge, he was admitted to our department again due to adrenal insufficiency and thyrotoxicosis with elevated serum TSH levels, suggesting cyclic SITSH. Although resistance to thyroid hormone (RTH) was not completely excluded, the pituitary tumor was removed by transsphenoidal surgery (TSS). A pathological diagnosis confirmed TSHoma. We herein report a case of TSHoma in which serum TSH, FT3, and FT4 levels fluctuated periodically. To the best of our knowledge, this is the first case report of "cyclic TSHoma", which needs to be considered when making a differential diagnosis of SITSH.

Entities:  

Keywords:  Cyclic fluctuation of serum TSH levels; TSH-secreting pituitary adenoma

Mesh:

Substances:

Year:  2018        PMID: 29695647     DOI: 10.1507/endocrj.EJ18-0006

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

Review 1.  A 2019 update on TSH-secreting pituitary adenomas.

Authors:  P Beck-Peccoz; C Giavoli; A Lania
Journal:  J Endocrinol Invest       Date:  2019-06-07       Impact factor: 4.256

Review 2.  Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor.

Authors:  Peiqiong Luo; Lin Zhang; Lidan Yang; Zhenmei An; Huiwen Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-27       Impact factor: 5.555

3.  Syndrome of inappropriate secretion of thyroid-stimulating hormone in a subject with galactorrhea and menstrual disorder and undergoing infertility treatment: Case report.

Authors:  Hideaki Kaneto; Shinji Kamei; Fuminori Tatsumi; Masashi Shimoda; Tomohiko Kimura; Atsushi Obata; Takatoshi Anno; Shuhei Nakanishi; Kohei Kaku; Tomoatsu Mune
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

4.  Development of a preoperative index-based nomogram for the prediction of hypokalemia in patients with pituitary adenoma: a retrospective cohort study.

Authors:  Wenpeng Li; Lexiang Zeng; Deping Han; Shanyi Zhang; Bingxi Lei; Meiguang Zheng; Yuefei Deng; Lili You
Journal:  PeerJ       Date:  2021-07-19       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.